Comparing Resource Use In Alzheimer's Disease Across Three European Countries - 18-Month Results of The Geras Study.

• Studies from several European countries have shown that the total societal costs of caring for patients with Alzheimer’s disease (AD) vary across countries and regions.1,2 • Differences between countries and regions in healthcare system structure and resource availability have a direct impact on resource utilization and costs. • Some data on resource utilization in AD in Europe exist,2 but few studies have examined resource use in multiple countries, included a large sample size and prospective follow-up, used standardized measures of resource use, or included the full range of AD severities.1,2 • GERAS was a prospective cohort study conducted in France, Germany and the UK, designed to evaluate resource use and costs associated with AD for community-dwelling patients and their caregivers.3 • Baseline data from GERAS showed that resource use and costs increased with AD severity.3